Characteristics, impact and treatment of 6000 headache attacks: The PAMINA study

European Journal of Pain

Volumn 15, Issue 2, 2011, Pages 205-212

  Lieba Samal, Doris ^a   Wöber, Christian ^a   Weber, Michael ^a   Schmidt, Karin ^a   Wöber Bingöl, Ciek ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Characteristics; Impact; Medication; Migraine

Indexed keywords

ANALGESIC AGENT; ERGOTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRYPTAMINES;

EID: 79251598020     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2010.06.013     Document Type: Article

References (40)

1. P. Andlin-Sobocki, B. Jonsson, H.U. Wittchen, and J. Olesen Cost of disorders of the brain in Europe Eur J Neurol 12 Suppl. 1 2005 1 27
2. D.M. Ashcroft, and D. Millson Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials Pharmacoepidemiol Drug Safety 13 2 2004 73 82
3. M.A. Ceballos Hernansanz, R. Sanchez Roy, A. Cano Orgaz, and A. López-Gil START 10 Study Group. Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness Clin Ther 25 7 2003 2053 2069
4. D. Cologno, P. Torelli, and G.C. Manzoni A prospective study of the headache phase in 32 migraine with aura patients Cephalalgia 22 6 2002 411 415
5. P. Cortelli, C. Dahlof, J. Bouchard, J. Heywood, J.P. Jansen, and S. Pham A multinational investigation of the impact of subcutaneous sumatriptan. III: workplace productivity and non-workplace activity Pharmacoeconomics 11 Suppl. 1 1997 35 42
6. C. Dahlof, J. Bouchard, P. Cortelli, J. Heywood, J.P. Jansen, and S. Pham A multinational investigation of the impact of subcutaneous sumatriptan. II: health-related quality of life Pharmacoeconomics 11 Suppl. 1 1997 24 34 (Pubitemid 27286105)
7. V. Di Monda, M. Nicolodi, A. Aloisio, P. Del Bianco, M. Fonzari, and I. Grazioli Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial Headache 43 8 2003 835 844
8. S. Diamond, M.E. Bigal, S. Silberstein, E. Loder, M. Reed, and R.B. Lipton Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study Headache 47 3 2007 355 363
9. H.C. Diener, V. Pfaffenrath, L. Pageler, H. Peil, B. Aicher, and R.B. Lipton Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics Cephalalgia 29 2 2009 188 193
10. A.J. Dowson Assessing the impact of migraine Curr Med Res Opin 17 4 2001 298 309
11. M.K. Eriksen, L.L. Thomsen, and J. Olesen New international classification of migraine with aura (ICHD-2) applied to 362 migraine patients Eur J Neurol 11 9 2004 583 591
12. M.D. Ferrari, K.I. Roon, R.B. Lipton, and P.J. Goadsby Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials Lancet 358 9294 2001 1668 1675
13. G. Geraud, A. Compagnon, and A. Rossi Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study Eur Neurol 47 2 2002 88 98
14. S.W. Hamelsky, R.B. Lipton, and W.F. Stewart An assessment of the burden of migraine using the willingness to pay model Cephalalgia 25 2 2005 87 100
15. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia 2004;24 (Suppl. 1):9-160.
16. L. Kelman Validation of the classification of migraine without aura (IHS A1.1) proposed in ICHD-2 Headache 45 10 2005 1339 1344
17. L. Kelman Pain characteristics of the acute migraine attack Headache 46 6 2006 942 953
18. M. Lanteri-Minet, D. Valade, G. Geraud, M.H. Chautard, and C. Lucas Migraine and probable migraine-results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification Cephalalgia 25 12 2005 1146 1158
19. D. Lieba-Samal, S. Bartl, S. Salhofer, A. Prajsnar, R. Massl, and E. Freydl The course of migraine - a diary study in unselected patients Cephalalgia 29 10 2009 1049 1058
20. M. Linde, A. Mellberg, and C. Dahlof The natural course of migraine attacks. A prospective analysis of untreated attacks compared with attacks treated with a triptan Cephalalgia 26 6 2006 712 721
21. R.B. Lipton, W.F. Stewart, R. Cady, C. Hall, S. O'Quinn, and T. Kuhn 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study Headache 40 10 2000 783 791
22. R.B. Lipton, and W.F. Stewart Acute migraine therapy: do doctors understand what patients with migraine want from therapy Headache 39 Suppl. 2 1999 20 26
23. R.B. Lipton, W.F. Stewart, A.M. Stone, M.J. Lainez, and J.P. Sawyer Stratified care vs. step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: a randomized trial JAMA 284 20 2000 2599 2605
24. R.B. Lipton, R.K. Cady, W.F. Stewart, K. Wilks, and C. Hall Diagnostic lessons from the spectrum study Neurology 58 9 Suppl. 6 2002 S27 S31
25. R.B. Lipton, M.E. Bigal, and P.J. Goadsby Double-blind clinical trials of oral triptans vs. other classes of acute migraine medication - a review Cephalalgia 24 5 2004 321 332
26. C. Lucas, C. Chaffaut, M.A. Artaz, and M. Lanteri-Minet FRAMIG 2000: medical and therapeutic management of migraine in France Cephalalgia 25 4 2005 267 279
27. E.A. MacGregor, J. Brandes, and A. Eikermann Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey Headache 43 1 2003 19 26
28. D.C. McCrory, and R.N. Gray Oral sumatriptan for acute migraine Cochrane Database Syst Rev 3 2003 CD002915
29. L.E. Morillo, F. Alarcon, N. Aranaga, S. Aulet, E. Chapman, and L. Conterno Prevalence of migraine in Latin America Headache 45 2 2005 106 117
30. M.C. Narbone, M. Abbate, and S. Gangemi Acute drug treatment of migraine attack Neurol Sci 25 Suppl. 3 2004 S113 S118
31. A.D. Oldman, L.A. Smith, H.J. McQuay, and R.A. Moore Rizatriptan for acute migraine Cochrane Database Syst Rev 3 2001 CD003221
32. W. Pryse-Phillips, M. Aube, P. Bailey, W.J. Becker, A. Bellavance, and M. Gawel A clinical study of migraine evolution Headache 46 10 2006 1480 1486
33. B.K. Rasmussen, and J. Olesen Migraine with aura and migraine without aura: an epidemiological study Cephalalgia 12 4 1992 221 228 [discussion 186]
34. M.B. Russell, H.K. Iversen, and J. Olesen Improved description of the migraine aura by a diagnostic aura diary Cephalalgia 14 2 1994 107 117
35. S.D. Silberstein Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 55 6 2000 754 762
36. L.A. Smith, A.D. Oldman, H.J. McQuay, and R.A. Moore Eletriptan for acute migraine Cochrane Database Syst Rev 3 2001 CD003224
37. W.F. Stewart, R.B. Lipton, J. Whyte, A. Dowson, K. Kolodner, and J.N. Liberman An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score Neurology 53 5 1999 988 994 (Pubitemid 29442114)
38. W.F. Stewart, R.B. Lipton, and K. Kolodner Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms Headache 43 3 2003 258 265
39. L. Stovner, K. Hagen, R. Jensen, Z. Katsarava, R. Lipton, and A. Scher The global burden of headache: a documentation of headache prevalence and disability worldwide Cephalalgia 27 3 2007 193 210
40. C. Wöber, W. Brannath, K. Schmidt, M. Kapitan, E. Rudel, and P. Wessely Prospective analysis of factors related to migraine attacks: the PAMINA study Cephalalgia 27 4 2007 304 314